It severely compromises it
Which compound should you choose The right choice depends on your specific research goals, tolerance for side effects, budget, and whether you prefer monotherapy or combination approaches
Great for dense packing + natural results
We used FineGray sub-distribution hazard model analyses adjusted for sex and age to assess the association of sociodemographic variables, comorbidities and co-medications (defined in ESM Table 2) with the risk of treatment discontinuation
Each option has established indications, real benefits, and known limitations
MM: Owner and science director of NutriGuard Research, a nutraceutical company which, among other things, sells berberine and astaxanthin supplements